Vifor Pharma releases further positive study results and expands the collaboration with Fresenius Medical Care
. - Promising Phase II study results with pipeline product PA21 - Phase III study to start soon in collaboration with F…
. - Promising Phase II study results with pipeline product PA21 - Phase III study to start soon in collaboration with F…
. - Vielversprechende Ergebnisse in Phase-II-Studie mit Pipeline-Produkt PA21 - Phase-III-Studie soll bald gestartet we…
Vifor Pharma, the pharma business sector of the Galenica Group, and Roche (SIX: RO, ROG;OTCQX: RHHBY), today announced t…
Vifor Pharma, der Geschäftsbereich Pharma der Galenica Gruppe, und Roche (SIX: RO, ROG:OTCQX: RHHBY) haben heute bekannt…